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The absolute number of citations is only one indicator of the importance of a
particular paper, and is often not the most important measure of how a
particular paper influences subsequent scientific development or the
application of basic and applied science to clinical practice. The Editors
have selected six highly cited papers from the 200 most cited articles in the
JID as ‘‘Citation Classics.’’ These are pipers of high impact which
demonstrate in different ways how simple observations can generate wide
and expanding effects. They represent a varied selection of papers, including
basic research in cell biology and immunodermatology, a clinical trial,
development of new techniques in cell biology and pharmacology
(‘‘methods’’ papers), and a review article. Accompanying the first page of
each of these Citation Classics is an invited commentary on the importance
of the paper to cutaneous biology. Each of these six Citation Classics
represents an important advance in cutaneous biology.
The first Citation Classic is the most cited paper in the JID, entitled ‘‘The
Identification of Contact Allergens by Human Assay. III. The Maximization
Test: a Procedure for Screening and Rating Contact Sensitizers’’ [1] by Albert
Montgomery Kligman. The development of the maximization test is an
excellent example of the application of extensive knowledge of contact
hypersensitivity to the development of a practical assay of drugs as contact
sensitizers. The applicability of this assay was based on its foundation in
science, its extensive testing, and its eventual reliability. The high profile of
this paper also illustrates the strong relationship between cutaneous biology,
investigative dermatology, and the pharmaceutical and cosmetics industries.
A highly predictive and reliable assay such as the maximization test is
essential to the pharmaceutical and cosmetics industries. In the twenty years
since this paper was published, the partnership between cutaneous biologists
and industry has grown considerably. In 1988 some of the best science
relating to cutaneous pharmacology was performed in industrial labora-
tories, and was often published in the JID.
The second paper selected for commentary is ‘‘Oral Methoxsalen
Photochemotherapy for the Treatment of Psoriasis: A Cooperative Clinical
Trial’’ [2] by John W. Melski and 32 other participating investigators. This
paper is the third most cited paper in the JID, and is a follow-up to a paper
published in the New England Journal of Medicine [3], which is one of the
most highly cited papers in the history of that journal. No recent new
treatment in dermatology has had greater impact than PUVA, and this impact
is thoroughly documented in the commentary by Jeffrey Bernhard. The
‘‘PUVA Story’’ is a clear demonstration of how basic research can lead to
new clinical treatments, how better understanding of the mechanisms of
these therapies can expand their applications, and how effective treatments
must be thoroughly understood through careful longitudinal clinical studies
and directed basic research. The chronicle of photochemotherapy continues
in the pages of the JID: In 1988 two papers from the PUVA cooperative group
further document the long-term risks of non- melanoma skin cancer and
causes of death in PUVA-treated patients [4,5].
The third Citation Classic is only 42nd in the list of the 200 most cited
papers in the JID. This modest citation of 25 years ago was the first report of
the effects of the protein which would be termed Epidermal Growth Factor,
one of the prototype growth factors for which Stanley Cohen won the Nobel
Prize for Medicine (with Rita Levi-Montalcini) in 1986. The importance of
hormone-like growth factors in all aspects of biology has become
increasingly evident in the 25 years since Stanley Cohen first reported the
effect of EGF protein on epidermal thickness and keratinization in this classic
paper in the JID. Growth factors are central to normal growth, development,
and differentiation; in maintenance of homeostasis and repair of tissue
damage; and probably in many disease states such as autoimmunity and
cancer. The pages of the JID in its 50th Anniversary year are filled with
papers on the varied biologic effects of growth factors and cytokines on the
structure and function of the skin. This paper is a classic example of how
simple experimental observations can be expanded to affect large segments
of biology.
No single topic is better represented in the 200 most cited papers in the
JID than the epidermal Langerhans cell. The second most cited paper is that
by Michael Birbeck, Aodan Breathnach, and John Everall, which describes
the characteristic cytoplasmic granule found in Langerhans cells, which are
now universally known as Birbeck granules [6]. A number of papers in the
late 1960s by Aodan Breathnach and colleagues [7] and by Klaus Wolff and
Richard Winkelmann [8,9] further demonstrated the distribution and ATPase
staining characteristics of Langerhans cells, and began to address the
processing of exogenous proteins by these cells [10]. In the late 1970s, the
functional role of epidermal Langerhans cells was examined by increasingly
sophisticated ultrastructural techniques and by basic immunopathologic
approaches. The result was an explosion of new information on the role of
the Langerhans cell as an accessory cell or antigen-presenting cell in contact
hypersensitivity, allogeneic reactivity, and graft rejection. From this
Langerhans cell era there are a number of highly cited papers reporting
major investigative discoveries: description of the analogous functions of
Langerhans cells and macrophages by Georg Stingl, Stephen Katz, and
their colleagues [11,12]; description of the inhibitory effects of ultraviolet
radiation on Langerhans cell markers and function [13]; and the description
by Inga Silberberg, Rudolph Baer, and Jeanette Thorbecke of the inter-
action of Langerhans cells and lymphocytes in contact hypersensitivity
[14,15]. We have chosen to provide commentary on the landmark work
of the investigators from New York University because the concept
that Langerhans cells were functional components of the cutaneous
immune system was viewed as revolutionary when it was proposed. It
heralded a new period in immunodermatology. During the past 20 years,
the role of the skin as an immunologic organ has so expanded, that
we now recognize that the involvement of several different cell types,
cytokines and growth factors, combine to produce a truly exciting field of
investigation [16].
The ability to grow keratinocytes in cell culture under defined and
variable conditions has made a wide spectrum of studies in molecular and
cellular biology possible, and has facilitated important studies in immuno-
dermatology, the chemistry of matrix proteins and growth factors, and
keratinocyte differentiation. It has also provided the opportunity to study the
effects of drugs on the epidermis directly, and to use cultured autologous and
homologous epidermis as grafts for severe burns and ulcers. Three major
epidermal keratinocyte culture techniques have been developed and widely
employed: the fibroblast-feeder layer technique of James Rheinwald and
Howard Green [17], the collagen gel method of Marvin Karasek [18], and
the serum-free defined medium system of Steven Boyce and Richard Ham
[19]. We have selected the technique of Marvin Karasek and his
collaborators at Stanford for commentary, for this technique evolved through
three highly cited papers in the top 200 published in the JID in 1966, 1971,
and 1978 (number 136[19], number 87[20], and number 62[18]). The
advances facilitated by all of these techniques in a short time have been
remarkable. By 1983, the burst of investigation in basic and applied science
with the use of cultured human keratinocytes was so great that a special
supplemental issue of the JID was devoted to the topic ‘‘Biology of the
Keratinocyte in Vitro,’’ which were the proceedings of the 32nd Annual
Symposium on the Biology of the Skin [19].
The sixth Citation Classic is an example of another very important feature
of the JID: the review article. A number of highly cited reviews have
provided clear perspectives on important advances in cutaneous biology,
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such as ‘‘the Immunopathology of Pemphigus and Bullous Pemphigoid’’
(citation number 4 [20]), ‘‘DNA Damage and Repair in Light-Sensitive
Human Skin Disease’’ (number 11 [21]), ‘‘Interaction Between Keratinocytes
and Dendritic Cells’’ (number 29 [22]), ‘‘The Pathogenesis of Dermatitis
Herpetiformis’’ (number 44 [23]), ‘‘Defects in the Biochemistry of Collagen
in Disease of Connective Tissue’’ (number 64 [24]), ‘‘Animal and Human
Collagenases’’ (number 67 [25]), ‘‘Factors Regulating Growth and Pigmenta-
tion of Melanoma Cells’’ (number 79 [26]), ‘‘Pathogenic Mechanisms
of Drug-Induced Photosensitivity (number 112 [27]), and ‘‘Subsets of
Systemic Lupus Erythematosus’’ (number 181 [28]). For commentary we
have selected the review by Ernest Beutner, Bob Jordon, and Tad Chorzelski
[20], not just because it is the fourth most cited paper in the JID, but
because of the impact of cutaneous immunofluorescence in the diagnosis,
treatment, and scientific understanding of the bullous diseases. This is clearly
one of the best examples of basic research changing clinical practice.
Immunofluorescence allowed the clear separation of a number of confusing
bullous diseases which could not always be diagnosed by clinical
presentation or standard histopathology. The separation of pemphigoid from
pemphigus and from dermatitis herpetiformis facilitated the development
and evaluation of rational therapy, and the evaluation of distinct
immunomechamsms in these diseases. These techniques are standard in
all modern immunoder-matology laboratories, and have been expanded to
allow separation and study of acquired epidermolysis bullosa, chronic
bullous disease of childhood, and erythema multiforme. The contribution by
Gerald Krueger in the chapter ‘‘Immunology/Inflammation of the Skin: a Fifty
Year Perspective’’ in this issue more fully describes the progress in scientific
investigations of immunoreactants in the pathogenesis of the bullous
diseases.
These six Citation Classics provide other interesting perspectives on
the development of investigation in cutaneous biology, beyond the simple
story of laboratories, experiments, and discoveries. These commentaries
show us how important new concepts may grow from simple observations,
how important techniques are developed through perseverance, how
large multi-center trials and teamwork can produce important therapeutic
advances, and how revolutionary concepts eventually win acceptance.
They also illustrate the human side of investigation: the value of
medical students, residents, and junior faculty in important discoveries,
the importance of human volunteers and patients in developing new
techniques and treatments, and the importance of reviewers, editors, and
established investigators in promoting the development of new and
important concepts.
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